Fri, Oct 24, 2014, 7:38 AM EDT - U.S. Markets open in 1 hr 52 mins

Recent

% | $
Quotes you view appear here for quick access.

Savient Pharmaceuticals, Inc. Message Board

  • scottg64200 scottg64200 Jun 2, 2004 7:13 PM Flag

    If Clement doesn't work out,

    Bring back Fass!



    Sim Fass has served as Chief Executive Officer of the Company and President of BTG-Israel since May 1984 and as Chairman of the Board of Directors since March 1997. He has also been a Director of the Company since August 1983. Dr. Fass served as Chief Operating Officer of BTG-Israel from August 1983 to May 1987 and as President of Savient from May 1984 to May 1999. From April 1980 to August 1983, he was Vice President, General Manager of Wampole Laboratories, a division of Carter-Wallace, Inc., a company that manufactures health care related products. Prior to that, he held various positions at Pfizer Inc. from September 1969 until March 1980, including Director, Marketing Research and Planning, Pfizer Pharmaceuticals, and Vice President, Marketing and Sales, Pfizer Diagnostics Division of Pfizer Pharmaceutical and Group Marketing Manager of Pfizer Laboratories. Dr. Fass received his Ph.D. in developmental biology/biochemistry from the Massachusetts Institute of Technology.


    HOME PAGE

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SVNTQ
0.00190.0000(0.00%)May 30 3:56 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.